Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
IN THE SPOTLIGHT – REGEnLIFE: At the crossroads of medicine and physics – Pharmaceutiques Magazine No. 335 / March 2026
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
REGEnLIFE attempts to prove that advanced phototherapy can cure Alzheimer’s disease

Research. Regenlife is testing its technologies for Alzheimer’s disease at Biofortis in Nantes

The medtech company Regenlife is opening a new research centre at Biofortis (140 employees, €13 million turnover) in Nantes. This marks a further step “towards accelerating the recruitment of the 108 patients for the Light4life pivotal trial, aged between 55 and 85 and suffering from mild to moderate Alzheimer’s disease”, the company explains. Regenlife specialises in innovative photobiomodulation and neuromodulation technologies for the treatment of neurodegenerative diseases.

Share this article